Lincomycin Injectable (IV/IM) bulk supplier for pharma manufacturers

Lincomycin Injectable (Iv/Im) Suppliers & Bulk Manufacturers

Available Forms: Injectable (IV/IM)

Available Strengths: 600 mg/2 mL, 1 g/2 mL, 2 g/2 mL

Reference Brands: Lincocin (US & EU)

Lincomycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, causing bacterial cell death. It is effective against serious Gram-positive infections, including skin and bone abscesses. Benefits include rapid bacterial eradication, high efficacy against resistant strains, and suitability for severe infections when administered properly in hospital settings.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Lincomycin injectable is approved in the EU and US for severe bacterial infections, including skin, soft tissue, and bone infections. In the EU, brands like Lincocin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic options are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert regulatory support, dossier preparation, and compliance, visit PharmaTradz. We support seamless market access for lincomycin injectable formulations, adhering to European and US standards for safe, effective antimicrobial therapy.

Lincomycin Injectable (Iv/Im) — third party manufacturing & bulk supply

Lincomycin Injectable (Iv/Im) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lincomycin Injectable (Iv/Im) is supplied as Injectable (IV/IM) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lincomycin Injectable (Iv/Im) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lincomycin Injectable (Iv/Im) →

Back to Listing

Frequently Asked Questions

Lincomycin Injectable (IV/IM) is listed as Injectable (IV/IM) in 600 mg/2 mL, 1 g/2 mL, 2 g/2 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Lincomycin Injectable (IV/IM) is referenced against Lincocin (US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.